Correction: A novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation (Journal of Biological Chemistry (2014) 289 (3126-3137) DOI: 10.1074/jbc.M113.508044);A novel CXCR3-B Chemokine Receptor-induced Growth-inhibitory signal in cancer cells is Mediated through the Regulation of Bach-1 Protein and Nrf2 Protein Nuclear Translocation

Journal of Biological Chemistry

Volumn 289, Issue 6, 2014, Pages 3126-3137

  Balan, Murugabaskar ^a,b   Pal, Soumitro ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL PROLIFERATION; DISEASES; PROTEINS; TRANSCRIPTION;

ANTI-APOPTOTIC PROTEIN; APOPTOTIC CELL DEATH; BREAST CANCER CELLS; CANCER CELL APOPTOSIS; NUCLEAR LOCALIZATION; NUCLEAR TRANSLOCATIONS; POSITIVE TRANSCRIPTION; TRANSCRIPTIONAL LEVELS;

CELL SIGNALING;

BECLIN 1; CELL PROTEIN; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR3B; HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEAR PROTEIN; PROTEIN BACH 1; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN LC3B; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TRANSLOCATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

APOPTOSIS; CHEMOKINES; HEME OXYGENASE; NRF2; NUCLEAR TRANSPORT; SIGNAL TRANSDUCTION; SIGNALING;

ACTIVE TRANSPORT, CELL NUCLEUS; ALTERNATIVE SPLICING; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BCL-X PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; HEME OXYGENASE-1; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-E2-RELATED FACTOR 2; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN ISOFORMS; RECEPTORS, CXCR3;

EID: 84896694285     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.AAC120.014986     Document Type: Erratum

References (39)

1. Zlotnik, A., and Yoshie, O. (2000) Chemokines. A new classification system and their role in immunity. Immunity 12, 121-127
2. Balkwill, F., and Mantovani, A. (2001) Inflammation and cancer. Back to Virchow? Lancet 357, 539-545
3. Vandercappellen, J., Van Damme, J., and Struyf, S. (2008) The role of CXC chemokines and their receptors in cancer. Cancer Lett. 267, 226-244
4. Zipin-Roitman, A., Meshel, T., Sagi-Assif, O., Shalmon, B., Avivi, C., Pfeffer, R. M., Witz, I. P., and Ben-Baruch, A. (2007) CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res. 67, 3396-3405
5. Walser, T. C., Rifat, S., Ma, X., Kundu, N., Ward, C., Goloubeva, O., Johnson, M. G., Medina, J. C., Collins, T. L., and Fulton, A. M. (2006) Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer. Cancer Res. 66, 7701-7707
6. Suyama, T., Furuya, M., Nishiyama, M., Kasuya, Y., Kimura, S., Ichikawa, T., Ueda, T., Nikaido, T., Ito, H., and Ishikura, H. (2005) Up-regulation of the interferon-(IFN-)-inducible chemokines IFNinducible T-cell-chemoattractant and monokine induced by IFN-And of their receptor CXC receptor 3 in human renal cell carcinoma. Cancer 103, 258-267
7. Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E., Sunshine, M. J., Littman, D. R., Kuo, C. J., Wei, K., McMaster, B. E., Wright, K., Howard, M. C., and Schall, T. J. (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201-2213
8. Ma, X., Norsworthy, K., Kundu, N., Rodgers, W. H., Gimotty, P. A., Goloubeva, O., Lipsky, M., Li, Y., Holt, D., and Fulton, A. (2009) CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model. Mol. Cancer Ther. 8, 490-498
9. Proudfoot, A. E. (2002) Chemokine receptors. Multifaceted therapeutic targets. Nat. Rev. Immunol. 2, 106-115
10. Romagnani, P., Lasagni, L., Annunziato, F., Serio, M., and Romagnani, S. (2004) CXC chemokines. The regulatory link between inflammation and angiogenesis. Trends Immunol. 25, 201-209
11. Datta, D., Flaxenburg, J. A., Laxmanan, S., Geehan, C., Grimm, M., Waaga-Gasser, A. M., Briscoe, D. M., and Pal, S. (2006) Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells. Relevance for the development of human breast cancer. Cancer Res. 66, 9509-9518
12. Kawada, K., Hosogi, H., Sonoshita, M., Sakashita, H., Manabe, T., Shimahara, Y., Sakai, Y., Takabayashi, A., Oshima, M., and Taketo, M. M. (2007) Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene 26, 4679-4688
13. Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., Marra, F., Romagnani, S., Serio, M., and Romagnani, P. (2003) An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197, 1537-1549
14. Kelsen, S. G., Aksoy, M. O., Yang, Y., Shahabuddin, S., Litvin, J., Safadi, F., and Rogers, T. J. (2004) The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L584-591
15. Wu, Q., Dhir, R., and Wells, A. (2012) Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion. Mol. Cancer 11, 3
16. Datta, D., Contreras, A. G., Grimm, M., Waaga-Gasser, A. M., Briscoe, D. M., and Pal, S. (2008) Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression. J. Am. Soc. Nephrol. 19, 2437-2446
17. Datta, D., Banerjee, P., Gasser, M., Waaga-Gasser, A. M., and Pal, S. (2010) CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1. J. Biol. Chem. 285, 36842-36848
18. Gacci, M., Serni, S., Lapini, A., Vittori, G., Alessandrini, M., Nesi, G., Palli, D., and Carini, M. (2009) CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma. J. Urol. 181, 843-848
19. Shan, Y., Lambrecht, R. W., Ghaziani, T., Donohue, S. E., and Bonkovsky, H. L. (2004) Role of Bach-1 in regulation of heme oxygenase-1 in human liver cells. Insights from studies with small interfering RNAS. J. Biol. Chem. 279, 51769-51774
20. Suzuki, H., Tashiro, S., Hira, S., Sun, J., Yamazaki, C., Zenke, Y., Ikeda-Saito, M., Yoshida, M., and Igarashi, K. (2004) Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1. EMBO J. 23, 2544-2553
21. Alam, J., Wicks, C., Stewart, D., Gong, P., Touchard, C., Otterbein, S., Choi, A. M., Burow, M. E., and Tou, J. (2000) Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J. Biol. Chem. 275, 27694-27702
22. Ryter, S. W., and Choi, A. M. (2002) Heme oxygenase-1. Molecular mechanisms of gene expression in oxygen-related stress. Antioxid. Redox Signal. 4, 625-632
23. Sun, J., Brand, M., Zenke, Y., Tashiro, S., Groudine, M., and Igarashi, K. (2004) Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. Proc. Natl. Acad. Sci. U.S.A. 101, 1461-1466
24. Agarwal, A., and Nick, H. S. (2000) Renal response to tissue injury. Lessons from heme oxygenase-1 gene ablation and expression. J. Am. Soc. Nephrol. 11, 965-973
25. Nath, K. A. (2006) Heme oxygenase-1. A provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int. 70, 432-443
26. Jozkowicz, A., Was, H., and Dulak, J. (2007) Heme oxygenase-1 in tumors. Is it a false friend? Antioxid. Redox Signal. 9, 2099-2117
27. Banerjee, P., Basu, A., Datta, D., Gasser, M., Waaga-Gasser, A. M., and Pal, S. (2011) The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-Apoptotic signal. J. Biol. Chem. 286, 33580-33590
28. Kim, T. H., Hur, E. G., Kang, S. J., Kim, J. A., Thapa, D., Lee, Y. M., Ku, S. K., Jung, Y., and Kwak, M. K. (2011) NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1-. Cancer Res. 71, 2260-2275
29. Banerjee, P., Basu, A., Wegiel, B., Otterbein, L. E., Mizumura, K., Gasser, M., Waaga-Gasser, A. M., Choi, A. M., and Pal, S. (2012) Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis-And autophagy-regulating molecules. J. Biol. Chem. 287, 32113-32123
30. Jain, K., Paranandi, K. S., Sridharan, S., and Basu, A. (2013) Autophagy in breast cancer and its implications for therapy. Am. J. Cancer Res. 3, 251-265
31. Kimmelman, A. C. (2011) The dynamic nature of autophagy in cancer. Genes Dev. 25, 1999-2010
32. Suzuki, H., Tashiro, S., Sun, J., Doi, H., Satomi, S., and Igarashi, K. (2003) Cadmium induces nuclear export of Bach1, a transcriptional repressor of heme oxygenase-1 gene. J. Biol. Chem. 278, 49246-49253
33. Deng, Y. T., Huang, H. C., and Lin, J. K. (2010) Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol. Carcinog. 49, 141-151
34. Xu, K., Xu, P., Yao, J. F., Zhang, Y. G., Hou, W. K., and Lu, S. M. (2013) Reduced apoptosis correlates with enhanced autophagy in synovial tissues of rheumatoid arthritis. Inflamm. Res. 62, 229-237
35. Abedin, M. J., Wang, D., McDonnell, M. A., Lehmann, U., and Kelekar, A. (2007) Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 14, 500-510
36. Petrai, I., Rombouts, K., Lasagni, L., Annunziato, F., Cosmi, L., Romanelli, R. G., Sagrinati, C., Mazzinghi, B., Pinzani, M., Romagnani, S., Romagnani, P., and Marra, F. (2008) Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. Int. J. Biochem. Cell Biol. 40, 1764-1774
37. Grethe, S., and Pörn-Ares, M. I. (2006) p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-induced endothelial apoptosis. Cell Signal. 18, 531-540
38. Porras, A., Zuluaga, S., Black, E., Valladares, A., Alvarez, A. M., Ambrosino, C., Benito, M., and Nebreda, A. R. (2004) P38-mitogen-Activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol. Biol. Cell 15, 922-933
39. Naidu, S., Vijayan, V., Santoso, S., Kietzmann, T., and Immenschuh, S. (2009) Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene expression via Nrf2. J. Immunol. 182, 7048-7057